Get the Stockscreener App
9.83
10.95%
0.97
After Hours:
9.90
0.07
+0.71%
Rezolute Inc stock is traded at $9.83, with a volume of 3.98M.
It is up +10.95% in the last 24 hours and up +20.76% over the past month.
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
See More
Previous Close:
$8.86
Open:
$9.11
24h Volume:
3.98M
Relative Volume:
3.31
Market Cap:
$892.68M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-7.7402
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
+9.22%
1M Performance:
+20.76%
6M Performance:
+216.08%
1Y Performance:
+85.82%
1-Day Range:
$8.95
$10.04
1-Week Range:
$8.51
$10.04
52-Week Range:
$2.215
$10.04
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
9.83 | 804.74M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Momentum divergence signals in Rezolute Inc. chartEarnings Performance Report & Risk Controlled Stock Pick Alerts - newser.com
Price momentum metrics for Rezolute Inc. explainedEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
Rezolute amends executive contracts and ends at-the-market sale agreement - Investing.com Nigeria
Is Rezolute Inc. (6HV1) stock ideal for retirement investorsJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com
Will Rezolute Inc. (6HV1) stock announce special dividendTake Profit & Verified Swing Trading Watchlist - newser.com
Using R and stats models for Rezolute Inc. forecastingQuarterly Profit Review & Technical Pattern Based Signals - newser.com
Is Rezolute Inc. stock a smart buy before Fed meetingTrade Risk Assessment & Fast Gain Stock Tips - newser.com
Technical signs of recovery in Rezolute Inc.Inflation Watch & Low Drawdown Investment Ideas - newser.com
Rezolute Inc. stock momentum explainedJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
What candlestick patterns are forming on Rezolute Inc.Recession Risk & Weekly Chart Analysis and Guides - newser.com
Volume Summary: Will Rezolute Inc. (6HV1) stock announce special dividend2025 Top Decliners & Stepwise Swing Trade Plans - nchmf.gov.vn
Why Rezolute Inc. (6HV1) stock is favored by hedge fundsJuly 2025 Breakouts & Technical Entry and Exit Alerts - nchmf.gov.vn
Using RSI to spot recovery in Rezolute Inc.Profit Target & Technical Pattern Based Signals - newser.com
Applying Wyckoff theory to Rezolute Inc. stock2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Will Rezolute Inc. stock benefit from infrastructure spendingMarket Growth Review & Capital Protection Trade Alerts - newser.com
Rezolute to Participate in Upcoming Investor Conferences - The Manila Times
Three investor conferences Oct 22–Nov 20, 2025: Rezolute to hold one-on-one investor meetings - Stock Titan
Multi factor analysis applied to Rezolute Inc.Market Performance Recap & Expert Verified Movement Alerts - newser.com
Is Rezolute Inc. stock ready for a breakout2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug - MSN
Here's Why We're Not Too Worried About Rezolute's (NASDAQ:RZLT) Cash Burn Situation - Sahm
Rezolute Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener
Can Rezolute Inc. stock sustain free cash flow growthMarket Trend Review & High Conviction Buy Zone Alerts - newser.com
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):